@sexedtok's low testosterone claims need more context

What did @sexedtok actually say?

The claim is straightforward: "the three main ways to treat men with low testosterone are topicals, weekly injections, or once every three months with the bioidentical pallets." That's a pretty tidy summary of TRT delivery methods, but it leaves out enough that it's worth pulling apart. The word "bioidentical" is doing some heavy lifting here, and the injection frequency and spelling of "pellets" both raise flags worth addressing.

To be fair, this is a short-form TikTok reply, not a clinical review. The creator isn't claiming to be exhaustive. But 60,000+ viewers are taking notes, and imprecision in this space has real consequences when people walk into a doctor's office or an online clinic with half the picture.

Does the science back this up?

Partially, yes. The three categories mentioned, topical gels or creams, injectable testosterone, and subcutaneous pellets, are all legitimate, FDA-recognized delivery methods for hypogonadism treatment. The clinical framework holds up. Where it starts to wobble is in the details.

Injectable testosterone is not exclusively a weekly thing. Testosterone cypionate and enanthate are commonly dosed every 7-14 days, while testosterone undecanoate (Aveed in the U.S.) is injected every 10 weeks after an initial loading period, per FDA labeling. A 2018 review by Mulhall et al. in the Journal of Urology confirmed that injection intervals vary significantly by formulation. Collapsing all injectables into "weekly" misses that range entirely.

Pellets are also more nuanced. The 3-month window is on the short end. Most clinical protocols and manufacturer guidance suggest pellet redosing every 3-6 months depending on dose and individual metabolism. Research by Bhagra et al. (2007, Mayo Clinic Proceedings) found pellet duration varies widely between patients, which is exactly why practitioners monitor levels before re-implanting.

What did they get wrong (or right)?

Let's give credit where it's due: the three broad categories, topicals, injectables, pellets, are genuinely the most common delivery systems in use today. That part is accurate. Most men on TRT are using one of those three. The creator isn't inventing anything.

But "bioidentical pallets" is where things get sloppy. First, it's pellets, not pallets. Second, and more importantly, "bioidentical" is a marketing term, not a pharmacological one. The FDA does not recognize "bioidentical" as a clinical classification. Testosterone pellets are either FDA-approved compounded preparations or, in some cases, custom-compounded by pharmacies. Calling them bioidentical implies a special naturalness or equivalency that regulators and endocrinologists have repeatedly pushed back on. The Endocrine Society's 2020 clinical practice guideline specifically cautions against using bioidentical hormone terminology as a quality marker.

The video also omits nasal gels (Natesto), buccal systems (Striant), and oral testosterone undecanoate (Jatenzo, Tlando), all of which are FDA-approved and used in practice. Saying these are the three ways isn't technically wrong, but calling them the main ways without that context is an oversimplification that could steer patients away from options that might actually suit them better.

What should you actually know?

If you're exploring TRT, the delivery method matters more than most people realize. It affects your dosing schedule, your hormone stability between doses, your skin-to-skin transfer risk if you have kids or a partner, and how your body responds over time.

Injectables can cause testosterone peaks and troughs that some men find uncomfortable. Topicals offer more stable daily levels but carry transfer risk and vary in absorption. Pellets provide steady release but require a minor in-office procedure every few months, and if the dose is wrong, you can't adjust it until the next insertion.

A 2021 study by Ramasamy et al. in Translational Andrology and Urology found that patient satisfaction with TRT varies significantly by delivery method, and that matching the method to the patient's lifestyle and clinical profile improves adherence. The best method isn't universal. It's the one that fits your labs, your life, and your prescriber's judgment. This is not a decision a TikTok video should be making for you.